Mechanism and targets of Sen1-dependent RNA polymerase II termination

Sen1依赖性RNA聚合酶II终止的机制和靶标

基本信息

  • 批准号:
    8429463
  • 负责人:
  • 金额:
    $ 26.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-15 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The realization that non-coding transcripts are remarkably abundant and participate in the regulation of protein- coding genes has revolutionized the study of eukaryotic gene expression. Yet little is known about how non- coding RNAs are made and function. We discovered an RNA polymerase II (Pol II) termination pathway that influences the synthesis and function many non-coding RNAs. This pathway requires the conserved helicase Sen1 and a collection of RNA-binding proteins that recognize the termination signal in the nascent transcript. The Sen1 pathway is essential in the model eukaryote S. cerevisiae (brewer's yeast), and mutations in the human Sen1 gene (SETX) cause the degeneration of motor neurons, leading to forms of ataxia and amyotrophic lateral sclerosis (ALS). Remarkably, Sen1-dependent termination regulates some protein-coding genes by transcription attenuation, which was previously thought to be restricted to bacteria. We will determine the molecular mechanism of Sen1-dependent termination using both genetic and biochemical approaches. Our structure/function studies will focus on two key proteins in the pathway, Sen1 and Pol II, in which we have isolated mutations that result in terminator read-through. Regulation of the IMD2 gene will be examined in detail as a paradigm for NTP homeostasis by Sen1-dependent attenuation and alternative start site selection. We will also identify and characterize new examples of Sen1-dependent gene regulation. The cis- and trans-acting determinants for regulation of these genes will be defined using genetic selections, quantitative gene expression assays, and mathematical modeling. The information gained in these studies will serve as a foundation for the investigation of RNA-based transcriptional regulation in other eukaryotes, including humans. Given the emerging evidence for the importance of non-coding transcripts in gene regulation in humans, our results will have broad implications for eukaryotic biology and human health, and will lead to a better understanding of the causes of motor neuron degeneration.
描述(申请人提供):认识到非编码转录本非常丰富,并参与蛋白质编码基因的调控,使真核基因表达的研究发生了革命性的变化。然而,关于非编码RNA是如何制造和发挥作用的,人们知之甚少。我们发现了一个影响许多非编码RNA合成和功能的RNA聚合酶II(POL II)终止途径。这一途径需要保守的解旋酶Sen1和一系列识别新生转录本中终止信号的RNA结合蛋白。Sen1通路在真核生物酿酒酵母模型中是必不可少的,人类Sen1基因(SETX)的突变会导致运动神经元的退化,导致共济失调和肌萎缩侧索硬化症(ALS)的形成。值得注意的是,Sen1依赖的终止通过转录衰减来调节一些蛋白质编码基因,这在以前被认为仅限于细菌。我们将用遗传学和生物化学方法来确定依赖Sen1终止的分子机制。我们的结构/功能研究将集中在该途径中的两个关键蛋白质Sen1和POL II上,在这两个蛋白质中,我们分离出了导致终结者通读的突变。IMD2基因的调节将作为NTP动态平衡的范例,通过依赖于Sen1的衰减和替代的起点选择进行详细的研究。我们还将识别和表征依赖于Sen1的基因调控的新例子。调控这些基因的顺式和反式决定因素将使用遗传选择、定量基因表达分析和数学建模来定义。从这些研究中获得的信息将作为研究其他真核生物,包括人类的基于RNA的转录调控的基础。鉴于越来越多的证据表明非编码转录本在人类基因调控中的重要性,我们的结果将对真核生物学和人类健康产生广泛的影响,并将有助于更好地理解运动神经元变性的原因。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A BROW其他文献

DAVID A BROW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A BROW', 18)}}的其他基金

RNA-based mechanisms in nuclear steps of gene expression
基因表达核步骤中基于 RNA 的机制
  • 批准号:
    10673582
  • 财政年份:
    2016
  • 资助金额:
    $ 26.39万
  • 项目类别:
RNA-based mechanisms in nuclear steps of gene expression
基因表达核步骤中基于 RNA 的机制
  • 批准号:
    10480746
  • 财政年份:
    2016
  • 资助金额:
    $ 26.39万
  • 项目类别:
RNA-based mechanisms in nuclear steps of gene expression
基因表达核步骤中基于 RNA 的机制
  • 批准号:
    10199159
  • 财政年份:
    2016
  • 资助金额:
    $ 26.39万
  • 项目类别:
RNA-based mechanisms in nuclear steps of gene expression
基因表达核步骤中基于 RNA 的机制
  • 批准号:
    9070879
  • 财政年份:
    2016
  • 资助金额:
    $ 26.39万
  • 项目类别:
Mechanism and targets of Sen1-dependent RNA polymerase II termination
Sen1依赖性RNA聚合酶II终止的机制和靶标
  • 批准号:
    7780908
  • 财政年份:
    2010
  • 资助金额:
    $ 26.39万
  • 项目类别:
Mechanism and targets of Sen1-dependent RNA polymerase II termination
Sen1依赖性RNA聚合酶II终止的机制和靶标
  • 批准号:
    8044008
  • 财政年份:
    2010
  • 资助金额:
    $ 26.39万
  • 项目类别:
Mechanism and targets of Sen1-dependent RNA polymerase II termination
Sen1依赖性RNA聚合酶II终止的机制和靶标
  • 批准号:
    8225301
  • 财政年份:
    2010
  • 资助金额:
    $ 26.39万
  • 项目类别:
Structure and Function of U6 Spliceosomal RNA
U6 剪接体 RNA 的结构和功能
  • 批准号:
    7371205
  • 财政年份:
    2002
  • 资助金额:
    $ 26.39万
  • 项目类别:
Structure and Function of U6 Spliceosomal RNA
U6 剪接体 RNA 的结构和功能
  • 批准号:
    8457657
  • 财政年份:
    2002
  • 资助金额:
    $ 26.39万
  • 项目类别:
Structure and Function of U6 Spliceosomal RNA
U6 剪接体 RNA 的结构和功能
  • 批准号:
    8440678
  • 财政年份:
    2002
  • 资助金额:
    $ 26.39万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 26.39万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 26.39万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 26.39万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 26.39万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 26.39万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 26.39万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 26.39万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 26.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 26.39万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 26.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了